永鼎股份(600105.SH):公司主營產品是第二代高温超導帶材及其應用設備,以及超導(通用)電氣產品
格隆匯8月4日丨有投資者向永鼎股份(600105.SH)提問,“請問貴公司有和中科院下屬公司研究超導材料或參與其中一項數據處理嘛?”,公司回覆稱,公司主營產品是第二代高温超導帶材及其應用設備,以及超導(通用)電氣產品。二代高温超導帶材可廣泛應用於風電、核電、電網、交通、醫療、軍事、重大科學工程等領域。電力方面,超導帶材代替傳統的銅材的應用產品有超導風機、超導電纜、可控核聚變堆、超導故障電流限流器、超導發電機等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.